Search results

  1. Patient4Life

    'Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder' A Reuters Investigation - Reuters Investigates

    Tainted Talc - by Reuters TV (Video)
  2. Patient4Life

    'Johnson & Johnson knew for decades that asbestos lurked in its Baby Powder' A Reuters Investigation - Reuters Investigates

    A Mount Sinai scientist told Johnson & Johnson he found small amounts of asbestos in its Baby Powder in 1971. J&J disagreed and put his name on an internal list of ‘antagonistic personalities’ - Reuters Top News - Twitter Johnson & Johnson knew for decades that asbestos lurked in its Baby...
  3. Patient4Life

    Scientists, ethicists slam decisions behind gene-edited twins: By John Timmer - ARS Technica

    Chinese scientists raise ethical questions with first gene-edited babies Science News - Tina Hesman Saey
  4. Patient4Life

    Scientists, ethicists slam decisions behind gene-edited twins: By John Timmer - ARS Technica

    Scientists, ethicists slam decisions behind gene-edited twins
  5. Patient4Life

    Caroline Struthers' correspondence and blog on the Cochrane Review: 'Exercise therapy for chronic fatigue syndrome, 2017 and 2019, Larun et al.

    Seems this type of fiasco is right up her ally of work.
  6. Patient4Life

    Autonomic dysfunction and HPV immunization: an overview. (2018) Blitshetyn et al.

    Autonomic dysfunction and HPV immunization: an overview.
  7. Patient4Life

    New Website on Severe ME

    :heart:
  8. Patient4Life

    Low-dose Naltrexone articles and experiences

    It didn't do anything for me and I tried it for a year but I heard it works for some.
  9. Patient4Life

    Erythrocyte Deformability As a Potential Biomarker for Chronic Fatigue Syndrome, Davis et al (2018)

    I looked at thread and didn't see the information Dr. Guthridge posted about the journal on Twitter.
  10. Patient4Life

    Wall Street Wants the Best Patents, Not the Best Drugs - Curing diseases like Hepatitis C just doesn’t pay. By Joe Nocera - Bloomberg Opinion

    Wall Street Wants the Best Patents, Not the Best Drugs - Curing diseases like Hepatitis C just doesn’t pay. By Joe Nocera - Bloomberg Opinion I agree!
View older results
Back
Top Bottom